Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090196

Director acquired 111,349 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Martell Christopher · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-25 Grant or award : show line 1 in the form +111,349 $4.67 $520,000 111,349 I
Loading xslF345X05/ownership.xml…